Oncogenetics

Breast and ovarian tumors, prostate cancer.

Oncogenetics deals with hereditary predispositions to the development of malignant tumor diseases. Approximately 5-10% of these diseases result from known mutations in genes involved in the body's defense mechanisms. Carriers of these mutations have a very high probability of developing tumor diseases during their lifetime. Individuals with confirmed highly-risky mutations in these genes receive much more thorough preventive care in specialized medical facilities, in comprehensive oncology centers.

Screening examination of variants in 4 genes predisposing to breast, ovarian, or prostate cancer.